FAQ

Skin looseness occurs when the skin loses its natural elasticity and firmness, making it vulnerable to gravity andexternal forces. This condition is typically attributed to several factors, including rapid weight loss within a short timeframe, depletion of collagen due to the aging process, or skin laxity following childbirth.

Renuvion, an FDA-approved, minimally invasive subcutaneous tightening technology, has obtained numerous safety certifications. It is particularly beneficial for individuals experiencing generalized skin laxity or collagen loss. Before considering Renuvion treatment, it is crucial to undergo a comprehensive evaluation by a qualified healthcare physician to determine its suitability for your specific needs.

Following Renuvion treatment, immediate skin tightening can be noticed, with optimal subcutaneous collagen proliferation typically becoming more apparent within 6-9 months post-treatment. The longevity of the skin tightening effects varies based on factors such as individual aging, overall health, physiological age, and adherence to maintenance practice, etc.

Renuvion is a minimally invasive procedure designed to minimize scarring and ensure safety. The incisions made during treatment are small and conducive to swift recovery. Scarring typically ranges from 0.3 cm to 0.5 cm in size and tends to fade within approximately six months to a year following surgery.

Recovery typically spans 2-3 weeks, during which pressure garments are often recommended for enhanced healing. However, individual recovery experiences may vary, and post-operative evaluation by a healthcare physician is essential to ensure optimal outcomes.

Individuals who are pregnant, have cardiac devices such as implantable defibrillators or pacemakers, suffer from hernias, are on anticoagulants, have autoimmune disorders, or experience impaired wound healing (e.g., due to diabetes) may encounter complications such as scarring or delayed wound healing. For those with any of these conditions, it is advisable to undergo a thorough consultation with a qualified healthcare physician to assess the suitability of Renuvion treatment.